168 research outputs found
Axial-slot Air Admission for Controlling Performance of a One-quarter-annulus Turbojet Combustor and Comparison with Complete Engine
An investigation of a single-annulus turbojet combustor with slot-type air admission was conducted to demonstrate the application of certain design principles to the control of outlet-gas temperature distributions. Comparisons of performance of a one-quarter-annulus combustor (duct-type installation) and a full-annulus combustor (obtained in a full-scale turbojet engine) are presented to indicate the applicability of results obtained from combustion studies conducted in duct-type installations. A reasonable correlation existed between the performance of the one-quarter-annulus and full-annulus combustors except for temperature distribution. Sufficient trends did exist which made it possible to predict temperature distributions for the engine, although absolute correlation did not exist. A radial temperature distribution similar to that required for a given engine was obtained using a one-quarter-annulus duct-type setup to predict results
A Model for the Two-Phase Behavior of Fluids in Dilute Porous Media
Experiments show that the coexistence region of a vapor-liquid system or binary liquid mixture is dramatically narrowed when the fluid is confined in a dilute porous medium such as a silica aerogel. We propose a simple model of the gel as a periodic array of cylindrical strands, and study the phase behavior of an Ising system confined in this geometry. Our results suggest that the coexistence region should widen out at lower temperatures, and that the narrowness observed near the critical point may be a fluctuation-induced effect
The Zel'dovich effect and evolution of atomic Rydberg spectra along the Periodic Table
In 1959 Ya. B. Zel'dovich predicted that the bound-state spectrum of the
non-relativistic Coulomb problem distorted at small distances by a short-range
potential undergoes a peculiar reconstruction whenever this potential alone
supports a low-energy scattering resonance. However documented experimental
evidence of this effect has been lacking. Previous theoretical studies of this
phenomenon were confined to the regime where the range of the short-ranged
potential is much smaller than Bohr's radius of the Coulomb field. We go beyond
this limitation by restricting ourselves to highly-excited s states. This
allows us to demonstrate that along the Periodic Table of elements the
Zel'dovich effect manifests itself as systematic periodic variation of the
Rydberg spectra with a period proportional to the cubic root of the atomic
number. This dependence, which is supported by analysis of experimental and
numerical data, has its origin in the binding properties of the ionic core of
the atom.Comment: 17 pages, 12 figure
The Development and Subsequent Elimination of Aberrant Peripheral Axon Projections in Semaphorin3A Null Mutant Mice
AbstractSemaphorin3A (previously known as Semaphorin III, Semaphorin D, or collapsin-1) is a member of the semaphorin gene family, many of which have been shown to guide axons during nervous system development. Semaphorin3A has been demonstrated to be a diffusible chemorepulsive molecule for axons of selected neuronal populations in vitro. Analysis of embryogenesis in two independent lines of Semaphorin3A knockout mice support the hypothesis that this molecule is an important guidance signal for neurons of the peripheral nervous system (M. Taniguchi et al., 1997, Neuron 19, 519–530; E. Ulupinar et al., 1999, Mol. Cell. Neurosci. 13, 281–292). Surprisingly, newborn Semaphorin3A null mutant mice exhibit no significant abnormalities (O. Behar et al., 1996, Nature 383, 525–528). In this study we have tested the hypothesis that guidance abnormalities that occurred during early stages of Semaphorin3A null mice development are corrected later in development. We have found that the extensive abnormalities formed during early developmental stages in the peripheral nervous system are largely eliminated by embryonic day 15.5. We demonstrate further that at least in one distinct anatomical location these abnormalities are mainly the result of aberrant projections. In conclusion, these findings suggest the existence of correction mechanisms that eliminate most sensory axon pathfinding errors early in development
The Chandra High Energy Transmission Grating: Design, Fabrication, Ground Calibration and Five Years in Flight
Details of the design, fabrication, ground and flight calibration of the High
Energy Transmission Grating, HETG, on the Chandra X-ray Observatory are
presented after five years of flight experience. Specifics include the theory
of phased transmission gratings as applied to the HETG, the Rowland design of
the spectrometer, details of the grating fabrication techniques, and the
results of ground testing and calibration of the HETG. For nearly six years the
HETG has operated essentially as designed, although it has presented some
subtle flight calibration effects.Comment: 34 pages (including 30 figures), accepted for publication in PAS
Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis
Allergic rhinitis is the most common clinical presentation of allergy, affecting 400 million people worldwide, with increasing incidence in westernized countries1,2. To elucidate the genetic architecture and understand the underlying disease mechanisms, we carried out a meta-analysis of allergic rhinitis in 59,762 cases and 152,358 controls of European ancestry and identified a total of 41 risk loci for allergic rhinitis, including 20 loci not previously associated with allergic rhinitis, which were confirmed in a replication phase of 60,720 cases and 618,527 controls. Functional annotation implicated genes involved in various immune pathways, and fine mapping of the HLA region suggested amino acid variants important for antigen binding. We further performed genome-wide association study (GWAS) analyses of allergic sensitization against inhalant allergens and nonallergic rhinitis, which suggested shared genetic mechanisms across rhinitis-related traits. Future studies of the identified loci and genes might identify novel targets for treatment and prevention of allergic rhinitis
Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe
Lewy bodies (LBs) appear in the brains of nondemented individuals and also occur in a range of neurodegenerative disorders, such as dementia with Lewy bodies (DLB) and Parkinson's disease. A number of people with a definite diagnosis of Alzheimer's disease (AD) also exhibit these intraneuronal inclusions in allo- and/or neocortical areas. The latter, referred to as Lewy body variant of AD (LBV), bears a clinical resemblance to AD in terms of age at onset, duration of illness, cognitive impairment, and illness severity. Since the presence of LBs is accompanied by neuronal cytoskeleton changes, it is possible that the latter may influence neuronal connectivity via alterations to the synaptic network. To address this, we examined the expression of synaptic proteins (synaptophysin, syntaxin, SNAP-25, and α-synuclein) and two cytoskeletal proteins (tau and MAP2) in the brain tissue of subjects enrolled in a population-based autopsy study (n = 47). They were divided into groups with no memory problems (control group, n = 15), LBV (n = 5), AD devoid of LBs (n = 17), cerebrovascular dementia (n = 3), and mixed dementia (n = 7). The LBV and AD groups had a similar degree of cognitive impairment and neuropathological staging in terms of Braak staging and CERAD score. In comparison with the control group and the dementia groups without LBs, the LBV group had significantly lower levels of syntaxin and SNAP-25 (23%) in the neocortex, and depletion of MAP2 (64%), SNAP-25 (34%), and α-synuclein (44%) proteins in the medial temporal lobes. These findings suggest that the t-SNARE complex deficit present in LBV may be associated with the presence of LB-related pathology and may explain the more profound cholinergic loss seen in these patients
Recommended from our members
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
Background: Borderline resectable pancreatic cancers infiltrate into adjacent vascular structures to an extent that makes an R0 resection unlikely when pancreatectomy is performed de novo. In a pilot study, Alliance for Clinical Trials in Oncology Trial A021101, the median survival of patients who received chemotherapy and radiation prior to anticipated pancreatectomy was 22 months, and 64% of operations achieved an R0 resection. However, the individual contributions of preoperative chemotherapy and radiation therapy to therapeutic outcome remain poorly defined. Methods: In Alliance for Clinical Oncology Trial A021501, a recently activated randomized phase II trial, patients (N = 134) with a CT or MRI showing a biopsy-confirmed pancreatic ductal adenocarcinoma that meets centrally-reviewed anatomic criteria for borderline resectable disease will be randomized to receive either 8 cycles of modified FOLFIRINOX (oxaliplatin 85 mg/m2, irinotecan 180 mg/m2, leucovorin 400 mg/m2 and infusional 5-fluorouracil 2400 mg/m2 over 2 days for 4 cycles) or to 7 cycles of modified FOLFIRINOX followed by stereotactic body radiation therapy (33–40 Gy in 5 fractions). Patients without evidence of disease progression following preoperative therapy will undergo pancreatectomy and will subsequently receive 4 cycles of postoperative modified FOLFOX6 (oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, bolus 5-fluorouracil 400 mg/m2, and infusional 5-fluorouracil 2400 mg/m2 over 2 days for 4 cycles). The primary endpoint is the 18-month overall survival rate of patients enrolled into each of the two treatment arms. An interim analysis of the R0 resection rate within each arm will be conducted to assess treatment futility after accrual of 30 patients. Secondary endpoints include rates of margin-negative resection and event-free survival. The primary analysis will compare the 18-month overall survival rate of each arm to a historical control rate of 50%. The trial is activated nationwide and eligible to be opened for accrual at any National Clinical Trials Network cooperative group member site. Discussion This study will help define standard preoperative treatment regimens for borderline resectable pancreatic cancer and position the superior arm for further evaluation in future phase III trials. Trial registration ClinicalTrials.gov: NCT02839343, registered July 14, 2016. Electronic supplementary material The online version of this article (doi:10.1186/s12885-017-3441-z) contains supplementary material, which is available to authorized users
- …